Asia Pacific Bioprocessing Facilities
$7,998 – $12,838
Featuring key Bioprocessing Facilities from China, Taiwan, Korea, Japan, India, SEA, and Australia! Asia-Pacific Bioprocessing Facilities report covers comprehensive information on parameters such as facility size, capacity, production technologies, types of biologics manufactured and much more. It provides readers a closer look into the facilities of Chugai, Hanmi, Daiichi Sankyo, Biocon (India & SEA), Beigene, Amgen (Singapore), GSK (Singapore) and more.
KEY TAKEAWAYS
- Insights on production processes various BioPharmas currently and plan to employ.
- Understand the facility expansion plans of key players in the industry.
- Identify potential clients who would be interested in your latest technology or service.
- The report also features checklists based on DesignFlex30 and highlights examples of companies that have constructed their facilities in a flexible manner catering to the fast-changing needs of the industry.
Related products
-
Asia-Pacific Biologic CMO Facilities
$5,998 – $10,698
-
Southeast Asia Bioprocessing Market
$5,998 – $10,698
